These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Drug treatments for polycystic ovary syndrome. Radosh L Am Fam Physician; 2009 Apr; 79(8):671-6. PubMed ID: 19405411 [TBL] [Abstract][Full Text] [Related]
43. The evaluation and treatment of androgen excess. Practice Committee of the American Society for Reproductive Medicine Fertil Steril; 2006 Nov; 86(5 Suppl 1):S241-7. PubMed ID: 17055833 [No Abstract] [Full Text] [Related]
44. Endocrinological markers for assessing hyperandrogenemia in women classified as having polycystic ovary syndrome (PCOS) according to the revised 2003 diagnostic criteria. Mueller A; Dittrich R; Binder H; Hoffmann I; Beckmann MW; Cupisti S Eur J Med Res; 2006 Dec; 11(12):540-4. PubMed ID: 17182367 [TBL] [Abstract][Full Text] [Related]
45. The clinical evaluation of hirsutism. Somani N; Harrison S; Bergfeld WF Dermatol Ther; 2008; 21(5):376-91. PubMed ID: 18844715 [TBL] [Abstract][Full Text] [Related]
46. Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome. Ben Ayed B; Dammak dit Mlik S; Ben Arab H; Trabelssi H; Chahtour H; Mathlouthi N; Dhuib M; Kassis M; Saiidane D; Trabelssi K; Guermazi M Tunis Med; 2009 Jan; 87(1):43-9. PubMed ID: 19522426 [TBL] [Abstract][Full Text] [Related]
48. Polycystic ovary syndrome in adolescents: (women's health series). Horn M; Geraci SA South Med J; 2013 Oct; 106(10):570-6. PubMed ID: 24096951 [TBL] [Abstract][Full Text] [Related]
54. Anovulation with or without PCO, hyperandrogenaemia and hyperinsulinaemia as promoters of endometrial and breast cancer. Papaioannou S; Tzafettas J Best Pract Res Clin Obstet Gynaecol; 2010 Feb; 24(1):19-27. PubMed ID: 19264556 [TBL] [Abstract][Full Text] [Related]
55. Polycystic ovary syndrome in pediatric obesity and diabetes. Dondi E; Tufano M; Vigone MC; Lucaccioni L; Pozzobon G; Ubertini G; Mozzillo E; Delvecchio M Minerva Pediatr (Torino); 2021 Dec; 73(6):523-536. PubMed ID: 34286948 [TBL] [Abstract][Full Text] [Related]
56. Androgen excess disorders in women: the severe insulin-resistant hyperandrogenic syndrome, HAIR-AN. Rager KM; Omar HA ScientificWorldJournal; 2006 Jan; 6():116-21. PubMed ID: 16435040 [TBL] [Abstract][Full Text] [Related]
57. [Polycystic ovary disease: clinical picture, diagnosis and methods of therapy]. Micić DD Med Pregl; 1992; 45(5-6):205-9. PubMed ID: 1365059 [TBL] [Abstract][Full Text] [Related]
58. TREATMENT OF METABOLIC ALTERATIONS IN POLYCYSTIC OVARY SYNDROME. Păvăleanu I; Gafiţanu D; Popovici D; Duceac LD; Păvăleanu M Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):258-63. PubMed ID: 27483702 [TBL] [Abstract][Full Text] [Related]